CXCL10 and systemic sclerosis: Previous serological analysis of CXCL10 and ECM remodelling has been shown to be dysregulated in VEDOSS in smaller cohorts [15–17], however in this study we have combined autologous sera and dermal analysis to gain further insight into the initiation of SSc progression.